Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
8.11
-0.01 (-0.12%)
May 29, 2026, 2:12 PM EDT - Market open
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $297.6 million as of May 29, 2026. Its market cap has increased by 479.04% in one year.
Market Cap
297.60M
Enterprise Value
666.88M
1-Year Change
479.04%
Ranking
Category
Stock Price
$8.11
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $297.60M, an increase of 542.56%. That is a compound annual growth rate of 30.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 297.96M | 30.32% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 313.64M |
| Abeona Therapeutics | 313.47M |
| Nautilus Biotechnology | 308.80M |
| Niagen Bioscience | 308.07M |
| Surrozen | 303.84M |
| YD Bio | 303.08M |
| Editas Medicine | 301.55M |
| Eledon Pharmaceuticals | 300.71M |